Disposition of cannabichromene, cannabidiol, and Δ9-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry

Journal of Analytical Toxicology

Volumn 34, Issue 8, 2010, Pages 516-520

  Poklis, Justin L ^a   Thompson, Candace C ^a   Long, Kelly A ^a   Lichtman, Aron H ^a   Poklis, Alphonse ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 HYDROXYTETRAHYDROCANNABINOL; 11 NOR DELTA 9 TETRAHYDROCANNABINOL 9 CARBOXYLIC ACID; ACETONITRILE; CANNABICHROMENE; CANNABIDIOL; CANNABIS; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CANNABIS SMOKING; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INHALATION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; MALE; MOUSE; NONHUMAN; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

CANNABIS SATIVA; MUS;

EID: 79954587400     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/34.8.516     Document Type: Article

References (13)

1. F. Grotenhermen. Pharmacokinetics and pharmacodynamic of cannabinoids. Pharmacokinet. 42: 327-360 (2003).
2. M.A. ElSohly and D. Slade. Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 78: 539- 548 (2005).
3. S.A. Ahmed, S.A. Ross, D. Slade, M.M. Radwan, F. Zulfigar, and M.A. ElSohly. Cannabinoid ester constituents from high-potency Cannabis sativa. J. Nat. Prod. 71: 536-542 (2008).
4. M.M. Radwan, S.A. Ross, S.A. Ahmed, D. Slade, F. Zulfigar, and M.A. ElSohly. Isolation and characterization of new cannabis constituents from a high potency variety. Planta Med. 74: 267- 272 (2008).
5. M.M. Radwan, M.A. ElSohly, D. Slade, S.A. Ahmed, I.A. Khan, and S.A. Ross. Biologically active cannabinoids from high-potency Cannabis sativa. J. Nat. Prod. 72: 906-911 (2009).
6. M.A. Huestis. Cannabis (Marijuana)-effects on human behavior and performance. Forensic Sci. Rev. 14: 15-60 (2002).
7. B. Brunet, C. Doucet, N. Venisse, T. Hauet, W. Hébrard, Y. Papet, G. Mauco, and P. Mura. Validation of Large White Pig as an animal model for study of cannabinoid metabolism: application to the study of THC distribution in tissues. Forensic Sci. Int. 161: 169-174 (2006).
8. S. Varvel, J. Wiley, R. Yang, D. Bridgen, K. Long, A. Lichtman, and B. Martin. Interactions between THC and cannabidiol in mouse models of cannabinoid activity. Psychopharmacology (Berl). 186: 226-234 (2006).
9. A.F. Hoffman, M. Oz, R. Yang, A.H. Lichtman, and C.R. Lupica. Opposing actions of (9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn. Mem. 14: 63-74 (2007).
10. S.B. Gauwiler, A. Scholer and J. Drewe. Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-Plasma and urine after small dose of Cannabis sativa extracts. J. Chromatogr. B 850: 515-522 (2007).
11. SOFT/AAFS Forensic Laboratory Guidelines, Version 2006, section 8.3 Method calibration and validation, pp 12-14.
12. A.H. Lichtman, J.L. Poklis, D.M. Wilson, A. Poklis, and B.R. Martin. The pharmacological activity of inhalation exposure to marijuana in mice. Drug Alcohol Depend. 63: 107-116 (2001).
13. R.L. Foltz, K.M. McGinnis, and D.M. Chinn. Quantitative measurement of delta-9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry. Biomed. Mass Spectrom. 10: 316-323 (1983).